Edition:
United States

Health News

Photo

AstraZeneca's immunotherapy drug wins key lung cancer approval Feb 17 2018

LONDON AstraZeneca's immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors.

More Headlines

Hospitalized older adults less often tested for flu

(Reuters Health) - Even though elderly people have the highest rates of hospitalization and death from influenza, a U.S. study suggests that older patients may be less likely to get tested for flu in the hospital.

Feb 16 2018

In-person license renewal may reduce crashes involving people with dementia

Reuters Health - Older adults with dementia may be less likely to get in car crashes when they’re required to renew their driver’s licenses in person, a U.S. study suggests.

Feb 16 2018
Photo

Pot Pharm: Booming Canada weed sector plots next-wave medicines

TORONTO Canopy Growth Corp, one of the world's biggest medical marijuana producers, now wants to take on the world's pharmaceutical giants. | Video

Feb 16 2018
Photo

Swiss skiers first athletes hit by norovirus at Games

PYEONGCHANG, South Korea Two Swiss freestyle skiers are the first athletes confirmed to have been hit by a highly contagious virus that causes vomiting and diarrhea at the Pyeongchang Winter Games, the Swiss Olympic team confirmed on Friday.

Health Watch Graphics